Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2004-10-28 | JEFFREY H. BUCHALTER, has served as Chairman of the Board since September 2004. Since September 2001 Mr. Buchalter has served as the President of Ilex Oncology, Inc. and Chief Executive Officer since January 2002. Mr. Buchalter has served as a Director of Ilex since February 2001. From 1997 to 2001, Mr. Buchalter was Group Vice President for the Worldwide Oncology Franchise at Pharmacia Corporation. From 1993 to 1997, Mr. Buchalter was a Group Director with American Home Products, Wyeth Ayerst Laboratories. |
| 2006-04-12 | Jeffrey H. Buchalter, age 48, has served as a director of the Company and as Chairman of the Board of Directors since September 2004 and as President and Chief Executive Officer since December 2004. Mr. Buchalter previously served as the President and Chief Executive Officer of Ilex Oncology, Inc. ... Mr. Buchalter was presented the Joseph F. Buckley Memorial Award from the American Cancer Society for commitment to cancer control and involvement in the pharmaceutical oncology field. |
| 2007-04-10 | Mr. Buchalter received his B.S. in finance from Seton Hall University, and an M.B.A. in marketing from Temple University. |
| 2008-04-16 | Mr. Buchalter received his B.S. in finance from Seton Hall University, and an M.B.A. in marketing from Temple University. Mr. Buchalter also serves as a member of the Board of Directors of TopoTarget A/S, a publicly held Danish biopharmaceutical company, and as Chairman of the Board of Directors of MacroGenics Inc., a private, venture-backed biotechnology company. |
| 2009-04-13 | Mr. Buchalter received his B.S. in finance from Seton Hall University, and an M.B.A. in marketing from Temple University. He has held executive roles in pharmaceutical companies. |
Data sourced from SEC filings. Last updated: 2025-07-01